U.S. License Holder:
Ipsen Biopharm Ltd.
Date of License:
DYSPORT (abobotulinumtoxinA) is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for:
The treatment of cervical dystonia in adults;
The temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients greater than 65 years of age;
The treatment of upper and lower limb spasticity in adults;
The treatment of upper limb spasticity in pediatric patients 2 years of age and older, excluding spasticity caused by cerebral palsy;
The treatment of lower limb spasticity in pediatric patients 2 years of age and older.
Inter Partes Review ProceedingsPTAB Portal
IPR Case No(s):
U.S. Patent No.
7,148,041 (Animal Product Free Media and Processes for Obtaining a Botulinum Toxin)
Galderma S.A.; Galderma Labs, LP; Galderma Labs, Inc.; Galderma R&D, SNC; Nestle Skin Health, Inc.
§ 102 Challenge
Claim Types Challenged Under § 102
§ 102 Challenge Instituted
§ 103 challenge
Claim Types Challenged Under § 103
§ 103 Challenge Instituted
Final Written Decision Issued
Final Written Decision (Adverse Judgment in Favor of Petitioner for Patent Owner Failure to Respond)